The ESMO symposium "Signalling Pathways – Targeting the HER/EGFR family in breast, lung and colorectal cancers" is a unique event which will mark the start of a series of events that ESMO will specifically dedicate to issues around the widely debated topic of personalised cancer medicine.
Academic clinical researchers and industry researchers alike will be guided by an extraordinary panel of experts through the challenges and the novelties that the dissection of biomarkers are continuously bringing to the oncology field.
200 attendees are expected from throughout Europe and the rest of the world.
Please visite the following link to view the full Signalling Pathways Conference Programme:
ESMO welcome media interested in obtaining information and reporting on cancer issues.
Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card, please fill out the following form: http://www.formstack.com/forms/esmo-signalling_patways_2013_barcelona.
Media registration in advance is strongly recommended. On-site registration will NOT be possible.
Media representatives are required to observe and abide by the "Signalling Pathways Media Policy".
If you already want to schedule interviews or for any additional question, please contact:
ESMO Press Office
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.